---
title: "Sage Therapeutics, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0ffeb65b-c6d5-4fb6-b66e-ab16a72115da
json: https://whiteintel.dev/api/public/dossier/0ffeb65b-c6d5-4fb6-b66e-ab16a72115da
identifier: gb-coh:4812455
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Sage Therapeutics, Inc.

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:4812455`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0ffeb65b-c6d5-4fb6-b66e-ab16a72115da  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0ffeb65b-c6d5-4fb6-b66e-ab16a72115da  

## Ownership & control

### Holdings / subsidiaries

- **SAGE THERAPEUTICS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/6c9d6dd9-46bd-543e-a9f2-ae3a2183a9dd

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Sage Therapeutics, Inc.**. Human view: https://whiteintel.dev/entity/0ffeb65b-c6d5-4fb6-b66e-ab16a72115da · Structured JSON: https://whiteintel.dev/api/public/dossier/0ffeb65b-c6d5-4fb6-b66e-ab16a72115da._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._